|
⚲
|
| Keyboard |
| Christopher Mirabelli | |
|---|---|
| Firm | |
| Address | 47 Thorndike Street Suite B11 Cambridge, MA 02141 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Leap Therapeutics Inc | 021-475708 | Director | 77.2 M of 77.2 M |
||
| ARO Biotherapeutics Co | 021-468913 | Director | 24.0 M of 100.0 M |
||
| ARO Biotherapeutics Co | 021-385223 | Director | 90.3 M of 90.3 M |
||
| Leap Therapeutics Inc | 021-299736 | Executive Officer | 18.0 M of 18.0 M |
||
| Proteostasis Therapeutics Inc | 021-247685 | Director | 22.0 M of 28.0 M |
||
| Theraclone Sciences Inc | 021-239360 | Director | 3.1 M of 4.4 M |
||
| Proteostasis Therapeutics Inc | 021-222928 | Director | 15.0 M of 15.0 M |
||
| Galleon Pharmaceuticals Inc | 021-206691 | Director | 1.5 M of 1.5 M |
||
| Theraclone Sciences Inc | 021-200360 | Director | 6.0 M of 6.4 M |
||
| Trevena Inc | 021-196667 | Director | 60.0 M of 60.0 M |
||
| Theraclone Sciences Inc | 021-193896 | Director | 4.0 M of 8.0 M |
||
| Synovex Corp | 021-185289 | Executive Officer | 3.5 M of 7.0 M |
||
| Theraclone Sciences Inc | 021-165656 | Director | 11.6 M of 11.6 M |
||
| Apofore Corp | 021-163739 | Executive Officer | 0.5 M of 10.0 M |
||
| Proteostasis Therapeutics Inc | 021-122527 | Director | 70.6 M of 81.8 M |
||
| Dekkun Corp | 021-153226 | Executive Officer | 9.9 M of 30.5 M |
||
| Anexon Inc | 021-149307 | Executive Officer | 2.0 M of 12.0 M |
||
| Anexon Inc | 021-149306 | Executive Officer | 2.0 M of 2.0 M |
||
| Anexon Inc | 021-149305 | Executive Officer | 3.0 M of 3.0 M |
||
| Anchortherapeutics Inc | 021-146793 | Director | 5.0 M of 15.0 M |
||
| Trevena Inc | 021-145133 | Director | 17.5 M of 41.0 M |
||
| Theraclone Sciences Inc | 021-71676 | Director | 1.5 M of 1.5 M |
||
| Ascent Therapeutics Inc | 021-110449 | Director | 19.0 M of 19.0 M |
||
| HCV Management VIII LLC | |||||
| Healthcare Ventures IX LP | 021-141176 | Director | of 250.0 M |
||
| Related People Network |
|---|
| Network #195 at Proteostasis Therapeutics Inc — files alongside 16 co-filers |